Pharmaceutical Executive
If policy makers crafting a Medicare pharmacy benefit are worried about heavy prescription spending by seniors, they should take a closer look at medication use by the five million disabled beneficiaries in the program of 40 million patients.
If policy makers crafting a Medicare pharmacy benefit are worried about heavy prescription spending by seniors, they should take a closer look at medication use by the five million disabled beneficiaries in the program of 40 million patients. Medicare provides healthcare coverage for individuals under 65 who are totally and permanently disabled. Many qualify for Medicaid pharmacy benefits, but their low incomes make paying for prescription medicines particularly burdensome, according to a report on "Medicare's Disabled Beneficiaries: The Forgotten Population in the Debate Over Drug Benefits" from the Commonwealth Fund and the Henry J. Kaiser Family Foundation. That population fills more prescriptions and spends more on medicines each year than the elderly. (See "The Other Medicare Patients.")
The Other Medicare Patients
Moreover, the report points out, disabled Medicare beneficiaries use a different mix of pharmaceuticals than seniors do. Most notable is the heavy use of psychotherapeutics and analgesics -both low on the list of drugs commonly used by Medicare patients. (See "One Program, Two Lists.")
One Program, Two Lists
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.